Circulating markers for prognosis of hepatocellular carcinoma (Q38103946)

28 August 2017

title

Circulating markers for prognosis of hepatocellular carcinoma (English)

1 reference

28 August 2017

Kwong-Fai Wong

1

1 reference

28 August 2017

Zhi Xu

2

1 reference

28 August 2017

Jinfei Chen

3

1 reference

28 August 2017

Nikki P Lee

4

1 reference

28 August 2017

John M Luk

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

6 May 2013

1 reference

Expert Opinion on Medical Diagnostics

28 August 2017

published in

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

319-329

1 reference

28 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Staging systems in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Sorafenib: a clinical and pharmacologic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Early HCC: diagnosis and molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Identification of serum CCL15 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (<or=2 cm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Why the need for qPCR publication guidelines?--The case for MIQE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Circulating tumor cells measurements in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.795146

10.1517/17530059.2013.795146

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference